ME3 ESTIMATING COST-EFFECTIVENESS IN THE ABSENCE OF HEAD-TO-HEAD CLINICAL TRIALS—EXAMPLES OF TWO RECENT TECHNOLOGY ASSESSMENTS FOR NICE

NS Hawkins, S Palmer, M Sculpher, D Epstein, AE Ades, G Lu
  • Value in Health, November 2003, Elsevier
  • DOI: 10.1016/s1098-3015(10)61585-9
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Professor Anthony E ADES